Green tea polyphenols for prostate cancer chemoprevention: A translational perspective

This publication has 79 references indexed in Scilit:

• Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis
  Oncogene, 2007
• Direct Inhibition of Insulin-Like Growth Factor-I Receptor Kinase Activity by (−)−Epigallocatechin-3-Gallate Regulates Cell Transformation
  Cancer Epidemiology, Biomarkers & Prevention, 2007
• Constitutive Overexpression of Nrf2-dependent Heme Oxygenase-1 in A549 Cells Contributes to Resistance to Apoptosis Induced by Epigallocatechin 3-Gallate
  Journal of Biological Chemistry, 2006
• Chemoprevention of Human Prostate Cancer by Oral Administration of Green Tea Catechins in Volunteers with High-Grade Prostate Intraepithelial Neoplasia: A Preliminary Report from a One-Year Proof-of-Principle Study
  Cancer Research, 2006
• A prospective clinical trial of green tea for hormone refractory prostate cancer: An evaluation of the complementary/alternative therapy approach
  Urologic Oncology: Seminars and Original Investigations, 2005
• Cell signaling pathways altered by natural chemopreventive agents
  Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2004
• Role of p53 and NF-κB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells
  Oncogene, 2003
• A Phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma
  Cancer, 2003
• Cyclooxygenases: Structural, Cellular, and Molecular Biology
  Annual Review of Biochemistry, 2000
• The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
  1999